Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Rader

Showing results (21-30 of 820) with videos related to

Pageof 82
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Novel approaches to the treatment of dyslipidemiaDaniel J Rader
Science Translational Medicine|June 6, 2014
New therapies for coronary artery disease: genetics provides a blueprintDaniel J Rader
JAMA|November 6, 2003
High-density lipoproteins as an emerging therapeutic target for atherosclerosisDaniel J Rader
The Journal of Clinical Investigation|December 5, 2006
Molecular regulation of HDL metabolism and function: implications for novel therapiesDaniel J Rader
Nature Clinical Practice. Cardiovascular Medicine|January 25, 2007
Mechanisms of disease: HDL metabolism as a target for novel therapiesDaniel J Rader
The New England Journal of Medicine|November 7, 2007
Illuminating HDL--is it still a viable therapeutic target?Daniel J Rader
Cardiovascular Research|July 17, 2014
Spotlight on HDL biology: new insights in metabolism, function, and translationDaniel J Rader
Nature|April 9, 2011
Cardiovascular disease: the diet-microbe morbid unionKimberly Rak, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2003
Genetics of increased HDL cholesterol levels: insights into the relationship between HDL metabolism and atherosclerosisMarina Cuchel, Daniel J Rader
Journal of the American College of Cardiology|November 13, 2007
Is the cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans?Marina Cuchel, Daniel J Rader
Pageof 82

Showing results (21-30 of 820) with videos related to

Sort By:
Pageof 82
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Novel approaches to the treatment of dyslipidemiaDaniel J Rader
Science Translational Medicine|June 6, 2014
New therapies for coronary artery disease: genetics provides a blueprintDaniel J Rader
JAMA|November 6, 2003
High-density lipoproteins as an emerging therapeutic target for atherosclerosisDaniel J Rader
The Journal of Clinical Investigation|December 5, 2006
Molecular regulation of HDL metabolism and function: implications for novel therapiesDaniel J Rader
Nature Clinical Practice. Cardiovascular Medicine|January 25, 2007
Mechanisms of disease: HDL metabolism as a target for novel therapiesDaniel J Rader
The New England Journal of Medicine|November 7, 2007
Illuminating HDL--is it still a viable therapeutic target?Daniel J Rader
Cardiovascular Research|July 17, 2014
Spotlight on HDL biology: new insights in metabolism, function, and translationDaniel J Rader
Nature|April 9, 2011
Cardiovascular disease: the diet-microbe morbid unionKimberly Rak, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2003
Genetics of increased HDL cholesterol levels: insights into the relationship between HDL metabolism and atherosclerosisMarina Cuchel, Daniel J Rader
Journal of the American College of Cardiology|November 13, 2007
Is the cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans?Marina Cuchel, Daniel J Rader
Pageof 82